CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytes.
BACKGROUND:Fractalkine/CX(3)CL1, a surface chemokine, binds to CX(3)CR1 expressed by different lymphocyte subsets. Since CX(3)CL1 has been detected in the germinal centres of secondary lymphoid tissue, in this study we have investigated CX(3)CR1 expression and function in human naïve, germinal centr...
Main Authors: | Anna Corcione, Elisa Ferretti, Maria Bertolotto, Franco Fais, Lizzia Raffaghello, Andrea Gregorio, Claudya Tenca, Luciano Ottonello, Claudio Gambini, Glaucia Furtado, Sergio Lira, Vito Pistoia |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-12-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2793522?pdf=render |
Similar Items
-
Correction: CXCR1 Is Expressed by Human B Lymphocytes and Mediates CXCL1 Driven Chemotaxis of Tonsil Centrocytes.
by: Anna Corcione, et al.
Published: (2010-01-01) -
Correction: CX3CR1 Is Expressed by Human B Lymphocytes and Mediates CX3CL1 Driven Chemotaxis of Tonsil Centrocytes
Published: (2010-01-01) -
Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies
by: Elisa Ferretti, et al.
Published: (2014-01-01) -
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
by: Lucas, A, et al.
Published: (2003) -
The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
by: Paulina Pawelec, et al.
Published: (2020-10-01)